IDEAYA Biosciences Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, IDEAYA Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $52.29. The average 1-year stock price forecast is 45.21% higher than the current stock price, while the lowest is $36 (-0.03%) and the highest is $66 (+83.28%).

Price Target: $52.29 (+45.21%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$36	$52.29	$50	$66
Change	-0.03%	+45.21%	+38.85%	+83.28%

Analyst Ratings

The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	13	13	13	13	11	11
Buy	3	3	3	3	3	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	18	18	18	18	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza Truist Financial	Truist Financial	Buy Maintains $65 → $63	Buy	Maintains	$65 → $63	+74.95%	Jul 7, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $53 → $48	Buy	Maintains	$53 → $48	+33.30%	Jul 7, 2026
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $30 → $50	Buy	Maintains	$30 → $50	+38.85%	Jun 16, 2026
Charles Zhu LifeSci Capital	LifeSci Capital	Buy Maintains $65 → $62	Buy	Maintains	$65 → $62	+72.17%	Jun 15, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $58	Buy	Reiterates	$58	+61.07%	Jun 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

33.77M

from 218.71M

-84.56%

from 218.71M

Revenue Next Year

116.68M

from 33.77M

245.54%

from 33.77M

EPS This Year

-4.28

from -1.28

EPS Next Year

-3.65

from -4.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	27.94M	50.93M	23.39M	7.00M	218.71M	33.77M
Revenue Growth	43.01%	82.28%	-54.09%	-70.07%	3,024.43%	-84.56%
Operating Income	-50.27M	-62.50M	-134.43M	-326.98M	-159.31M	-419.03M
Net Income	-49.76M	-58.66M	-112.96M	-274.48M	-113.70M	-388.91M
EPS	-	-	-	-	-1.28	-4.28
Free Cash Flow	-15.64M	-42.37M	-70.28M	-155.09M	-52.47M	-346.61M
No. Analysts	-	-	-	-	-	16

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	85.5M
Avg	33.8M
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-60.9%
Avg	-84.6%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.49
Avg	-4.28
Low	-5.00

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-